CorMedix (CRMD) Operating Margin: 2012-2025
Historic Operating Margin for CorMedix (CRMD) over the last 12 years, with Sep 2025 value amounting to 49.24%.
- CorMedix's Operating Margin rose 7794.00% to 49.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 48.51%, marking a year-over-year increase of 44897.00%. This contributed to the annual value of -51.43% for FY2024, which is 14280215.00% down from last year.
- CorMedix's Operating Margin amounted to 49.24% in Q3 2025, which was up 0.12% from 49.18% recorded in Q2 2025.
- CorMedix's Operating Margin's 5-year high stood at 233,386.61% during Q2 2024, with a 5-year trough of -102,126.07% in Q3 2022.
- In the last 3 years, CorMedix's Operating Margin had a median value of 39,937.60% in 2023 and averaged 81,050.86%.
- In the last 5 years, CorMedix's Operating Margin skyrocketed by 24,052,633bps in 2023 and then tumbled by 23,333,743bps in 2025.
- Quarterly analysis of 5 years shows CorMedix's Operating Margin stood at -13,794.92% in 2021, then slumped by 1,444,974bps to -28,244.66% in 2022, then skyrocketed by 18,194,978bps to 79,823.71% in 2023, then slumped by 7,985,240bps to 41.45% in 2024, then surged by 7,794bps to 49.24% in 2025.
- Its Operating Margin stands at 49.24% for Q3 2025, versus 49.18% for Q2 2025 and 51.50% for Q1 2025.